BioSpace News Archive

Eli Lilly Sells Two Legacy Drugs and Manufacturing Facility in China for $375M

Eddingpharm forked over $375 million for the rights to sell Ceclor and Vancocin in China, as well as a manufacturing facility that makes the two medications.

April 23, 2019
·
2 min read
·
Alex Keown
Biotech Bay

Google Steps Up Efforts to Use Artificial Intelligence in Health Care

Artificial intelligence (AI) is increasingly seen as a tool in biopharma and life sciences to improve drug development. Google, as one of the biggest corporations on Earth, is very interested in the use of AI and health care.

April 23, 2019
·
4 min read
·
Mark Terry
Drug Development

Teva Pharma Halts Development of Cluster Headache Drug

Israel-based Teva Pharmaceuticals announced that it is halting the clinical development of fremanezumab (Ajovy) for cluster headaches. They based the decision on a pre-specified futility analysis of a Phase III clinical trial in episodic cluster headaches.

April 23, 2019
·
3 min read
·
Mark Terry
Business

GenFit Moves Lead Candidate into Another Phase III Trial with Breakthrough Therapy

GenFit’s lead product candidate elafibranor snagged Breakthrough Therapy Designation from the U.S. Food and Drug Administration as a treatment for Primary Biliary Cholangitis (PBC) following strong Phase II results that demonstrated the safety and efficacy of the medication.

April 23, 2019
·
3 min read
·
Alex Keown
BioCapital

IQVIA Report: Biopharma R&D Investment Has Increased 32% Over Last 5 Years

The IQVIA Institute for Human Data Science released a new report titled, “The Changing Landscape of Research and Development: Innovation, Drivers of Change, and Evolution of Clinical Trial Productivity.”

April 23, 2019
·
3 min read
·
Mark Terry
Job Trends

Georgia’s Life Sciences Business Grew More than 14% in 2018, Outpaces National Growth

The life sciences industry has seen significant growth over the past 10 years in Georgia. From 2007 to 2017, employment in the Peach State’s industry sciences grew by 14.9 percent. That growth outpaced the 7.7 percent national growth, Georgia Bio announced.

April 23, 2019
·
3 min read
·
Alex Keown
Policy

Anti-Vaxxer Movement Cites Distrust of Pharma Industry as Big Reason to Skip Shots

Over the past few years there seems to be a growing number of people in the United States who, for a myriad of reasons, opt out of vaccinating their children against common pathogens that often have deadly effects – like the measles.

April 23, 2019
·
2 min read
·
Alex Keown
Business

Planned Emeryville Life Sciences Development Challenged by Competing Developer

The rival developer appealed the recently approved 150,000 square foot development, saying it would shrink the amount of space between buildings.

April 23, 2019
·
2 min read
·
Alex Keown
Business

UK-Based Accelerator Start Codon Launches with Investment from Genentech and Others

Start Codon launched in Cambridge, England with funding from keystone investors including Cambridge Innovation Capital, Babraham Bioscience Technologies, Genentech, Jonathan Milner and Ian Tomlinson. Start Codon is a strategic initiative that’s targeting translating research into commercial companies.

April 23, 2019
·
2 min read
·
Mark Terry
Genetown

Mispro Launches Insourcing Services for Vivarium Research Facilities

Cambridge Vivarium Space & Services Provider Expands its Offerings to Include On-Site Solutions

April 23, 2019
·
3 min read